Henry Bilas

Henry Bilas

Manager, Manufacturing Car T Media Preparation @ Bristol Myers Squibb

About Henry Bilas

Henry Bilas is the Manager of Manufacturing CAR-T Media Preparation at Bristol-Myers Squibb in Summit, New Jersey, with extensive experience in operations management and manufacturing in the medical device industry.

Company

Henry Bilas is currently employed at Bristol-Myers Squibb, a prominent biopharmaceutical company. He occupies the role of Manager in the Manufacturing CAR-T Media Preparation segment. Bristol-Myers Squibb is known for its strong emphasis on research and development in the medical field, particularly in the area of innovative cancer treatments.

Title

Henry Bilas holds the title of Manager, Manufacturing CAR-T Media Preparation at Bristol-Myers Squibb. His role involves overseeing the production processes involved in the preparation of media used for CAR-T cell therapy, a cutting-edge treatment for cancer.

Education and Expertise

Henry Bilas earned a BA in Management and Marketing from Upsala College, completing his studies from 1979 to 1983. He has expertise in operations management and manufacturing, particularly in the medical device industry. His skill set includes proficiency in the DMAIC methodology and Value Stream Mapping. He also has a solid background in negotiation, essential for effective operations and supply chain management.

Background

Henry Bilas has amassed diverse experience in multiple companies. His career includes a variety of roles such as Manufacturing Manager at Turbine Technologies, Supervisor of Processing at MTF, and Materials Control Manager at Howmet Castings. He has consistently contributed to operations management and manufacturing, particularly in the medical device industry.

Experience in CAR-T Media Preparation

Since December 2019, Henry Bilas has been engaged in the field of CAR-T Media Preparation at Bristol-Myers Squibb. His contributions are pivotal to advancements in this specialized area of manufacturing, focusing on the production processes essential for CAR-T cell therapy, which represents a significant innovation in cancer treatment.

People similar to Henry Bilas